Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 94.

Marzel, A; Shilaih, Mohaned; Turk, T; Campbell, Nottania K; Yang, Wan-Lin; Böni, J; Yerly, S; Klimkait, T; Aubert, V; Furrer, H; Calmy, A; Battegay, M; Cavassini, M; Bernasconi, E; Schmid, P; Metzner, K J; Gunthard, H F; Kouyos, R D; Swiss HIV Cohort Study (SHCS), et al (2017). Mining for pairs: shared clinic visit dates identify steady HIV-positive partnerships. HIV Medicine, 18(9):667-676.

Kletenkov, K; Hoffmann, D; Böni, J; Yerly, S; Aubert, V; Schöni-Affolter, F; Struck, D; Verheyen, J; Klimkait, T (2017). Role of Gag mutations in PI resistance in the Swiss HIV cohort study: bystanders or contributors? Journal of Antimicrobial Chemotherapy, 72(3):866-875.

Huber, M; Metzner, K J; Geissberger, F D; Shah, C; Leemann, C; Klimkait, T; Böni, J; Trkola, A; Zagordi, O (2017). MinVar: A rapid and versatile tool for HIV-1 drug resistance genotyping by deep sequencing. Journal of Virological Methods, 240:7-13.

Bader, J; Däumer, M; Schöni-Affolter, F; Böni, J; Gorgievski-Hrisoho, Meri; Martinetti, G; Thielen, A; Klimkait, T (2016). Therapeutic Immune Recovery and Reduction of CXCR4-Tropic HIV-1. Clinical Infectious Diseases, 64(3):295-300.

Zbinden, A; Dürig, R; Shah, C; Böni, J; Schüpbach, J (2016). Importance of an Early HIV Antibody Differentiation Immunoassay for Detection of Dual Infection with HIV-1 and HIV-2. PLoS ONE, 11(6):online.

Schaerer, V; Haubitz, S; Kovari, H; Ledergerber, B; Ambrosioni, J; Cavassini, M; Stoeckle, M; Schmid, P; Decosterd, L; Aouri, M; Böni, J; Günthard, H F; Furrer, H; Metzner, K J; Fehr, J; Rauch, A (2015). Protease inhibitors to treat hepatitis C in the Swiss HIV Cohort Study: high efficacy but low treatment uptake. HIV Medicine, 16(10):599-607.

Vetter, B N; Orlowski, V; Fransen, K; Niederhauser, C; Aubert, V; Brandenberger, M; Ciardo, D; Dollenmaier, G; Klimkait, T; Regenass, S; Schmid, P; Schottstedt, V; Suter-Riniker, F; Yerly, S; Shah, C; Böni, J; Schüpbach, J (2014). Generation of a Recombinant Gag Virus-Like-Particle Panel for the Evaluation of p24 Antigen Detection by Diagnostic HIV Test. PLoS ONE, 9(10):e111552-e111552.

Metzner, K J; Scherrer, A U; von Wyl, V; Böni, J; Yerly, S; Klimkait, T; Aubert, V; Furrer, H; Hirsch, H; Vernazza, P L; Cavassini, M; Calmy, A; Bernasconi, E; Weber, R; Gunthard, H F (2014). Limited clinical benefit of minority K103N and Y181C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patients. AIDS, 28(15):2231-2239.

Kouyos, R D; Rauch, A; Braun, D L; Yang, W-L; Böni, J; Yerly, S; Klimkait, T; Aubert, V; Shah, C; Kovari, H; Calmy, A; Cavassini, M; Battegay, M; Vernazza, P L; Bernasconi, E; Ledergerber, B; Gunthard, H F (2014). Higher Risk of Incident Hepatitis C Virus Coinfection Among Men Who Have Sex With Men, in Whom the HIV Genetic Bottleneck at Transmission Was Wide. Journal of Infectious Diseases, 210(10):1555-1561.

Braun, D L; Rauch, A; Durisch, N; Eberhard, N; Anagnostopoulos, A; Ledergerber, B; Metzner, K J; Böni, J; Weber, R; Fehr, J (2014). Efficacy of lead-in silibinin and subsequent triple therapy in difficult-to-treat HIV/hepatitis C virus-coinfected patients. HIV Medicine, 15:625-630.

Vetter, B N; Shah, C; Huder, J B; Böni, J; Schüpbach, J (2014). Use of reverse-transcriptase-based HIV-1 viral load assessment to confirm low viral loads in newly diagnosed patients in Switzerland. BMC Infectious Diseases, 14:84.

Swenson, L C; Cobb, B; Geretti, A M; et al; Böni, J (2014). Comparative Performances of HIV-1 RNA Load Assays at Low Viral Load Levels: Results of an International Collaboration. Journal of Clinical Microbiology, 52(2):517-523.

Braun, D l; Rauch, A; Durisch, N; Eberhard, N; Anagnostopoulos, A; Ledergerber, B; Metzner, K J; Böni, J; Weber, R; Fehr, J (2014). Efficacy of lead-in silibinin and subsequent triple therapy in difficult-to-treat HIV/hepatitis C virus-coinfected patients. Neurobehavioral HIV Medicine, 15(10):625-630.

Hasse, B; Iff, M; Ledergerber, B; et al; Böni, J (2014). Obesity trends and body mass index changes after starting antiretroviral treatment: The Swiss HIV cohort study. Open Forum Infectious Diseases, 1(2):ofu040.

Stadler, T; Kouyos, R; von Wyl, V; Yerly, S; Böni, J; Bürgisser, P; Klimkait, T; Joos, B; Rieder, P; Xie, D; Günthard, H F; Drummond, A J; Bonhoeffer, S (2012). Estimating the Basic Reproductive Number from Viral Sequence Data. Molecular Biology and Evolution, 29(1):347-357.

von Wyl, V; Yerly, S; Böni, J; Shah, C; Cellerai, C; Klimkait, T; Battegay, M; Bernasconi, E; Cavassini, M; Furrer, H; Hirschel, B; Vernazza, P L; Ledergerber, B; Günthard, H F (2012). Incidence of HIV-1 drug resistance among antiretroviral treatment-naive individuals starting modern therapy combinations. Clinical Infectious Diseases, 54(1):131-140.

Scherrer, A U; von Wyl, V; Götte, M; Klimkait, T; Cellerai, C; Yerly, S; Böni, J; Held, L; Ledergerber, B; Günthard, H F (2012). Polymorphic mutations associated with the emergence of the multi-nucleoside/tide resistance mutations 69 insertion and Q151M. Journal of Acquired Immune Deficiency Syndromes, 59(2):105-112.

Damond, F; Benard, A; Balotta, C; Böni, J; Cotten, M; Duque, V; Ferns, B; Garson, J; Gomes, P; Gonçalves, F; Gottlieb, G; Kupfer, B; Ruelle, J; Rodes, B; Soriano, V; Wainberg, M; Taieb, A; Matheron, S; Chene, G; Brun-Vezinet, F (2011). An international collaboration to standardize HIV-2 viral load assays: results from the 2009 ACHI(E)V(2E) quality control study. Journal of Clinical Microbiology, 49(10):3491-3497.

Kouyos, R D; von Wyl, V; Yerly, S; Böni, J; Rieder, P; Joos, B; Taffé, P; Shah, C; Bürgisser, P; Klimkait, T; Weber, R; Hirschel, B; Cavassini, M; Rauch, A; Battegay, M; Vernazza, P L; Bernasconi, E; Ledergerber, B; Bonhoeffer, S; Günthard, H F (2011). Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection. Clinical Infectious Diseases, 52(4):532-539.

Oufir, M; Bisset, L R; Hoffmann, S R K; Xue, G; Klauser, S; Bergamaschi, B; Gervaix, A; Böni, J; Schüpbach, J; Gutte, B (2011). Artificial 64-residue HIV-1 enhancer-binding peptide is a potent inhibitor of viral replication in HIV-1-infected cells. Advances in Virology, 2011:165871.

Kouyos, R D; von Wyl, V; Hinkley, T; Petropoulos, C J; Haddad, M; Whitcomb, J M; Böni, J; Yerly, S; Cellerai, C; Klimkait, T; Günthard, H F; Bonhoeffer, S (2011). Assessing predicted HIV-1 replicative capacity in a clinical setting. PLoS Pathogens, 7(11):e1002321.

Rieder, P; Joos, B; Scherrer, A U; Kuster, H; Braun, D; Grube, C; Niederöst, B; Leemann, C; Gianella, S; Metzner, K J; Böni, J; Weber, R; Günthard, H F (2011). Characterization of human immunodeficiency virus type 1 (HIV-1) diversity and tropism in 145 patients with primary HIV-1 infection. Clinical Infectious Diseases, 53(12):1271-1279.

Young, J; Scherrer, A; Günthard, H; Opravil, M; Yerly, S; Böni, J; Rickenbach, M; Fux, C; Cavassini, M; Bernasconi, E; Vernazza, P; Hirschel, B; Battegay, M; Bucher, H (2011). Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort Study. HIV Medicine, 12(5):299-307.

Scherrer, A U; Ledergerber, B; von Wyl, V; Böni, J; Yerly, S; Klimkait, T; Bürgisser, P; Rauch, A; Hirschel, B; Cavassini, M; Elzi, L; Vernazza, P L; Bernasconi, E; Held, L; Günthard, H F (2011). Improved virological outcome in white patients infected with HIV-1 non-B subtypes compared to subtype B. Clinical Infectious Diseases, 53(11):1143-1152.

Bansal, V; Metzner, K J; Niederost, B; Leemann, C; Böni, J; Gunthard, H F; Fehr, J S (2011). Minority K65R variants and early failure of antiretroviral therapy in HIV-1-infected Eritrean Immigrant. Emerging Infectious Diseases, 17(10):1966-1968.

Scherrer, A U; von Wyl, V; Joos, B; Klimkait, T; Bürgisser, P; Yerly, S; Böni, J; Ledergerber, B; Günthard, H F (2011). Predictors for the emergence of the 2 multi-nucleoside/nucleotide resistance mutations 69 insertion and Q151M and their impact on clinical outcome in the Swiss HIV cohort study. Journal of Infectious Diseases, 203(6):791-797.

Fehr, J; Glass, T R; Louvel, S; Hamy, F; Hirsch, H H; von Wyl, V; Böni, J; Yerly, S; Bürgisser, P; Cavassini, M; Fux, C A; Hirschel, B; Vernazza, P; Martinetti, G; Bernasconi, E; Günthard, H F; Battegay, M; Bucher, H C; Klimkait, T (2011). Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals--the Swiss HIV Cohort Study. Journal of Translational Medicine, 9:14.

von Wyl, V; Kouyos, R D; Yerly, S; Böni, J; Shah, C; Bürgisser, P; Klimkait, T; Weber, R; Hirschel, B; Cavassini, M; Staehelin, C; Battegay, M; Vernazza, P L; Bernasconi, E; Ledergerber, B; Bonhoeffer, S; Günthard, H F (2011). The role of migration and domestic transmission in the spread of HIV-1 non-B subtypes in Switzerland. Journal of Infectious Diseases, 204(7):1095-1103.

Scherrer, A U; von Wyl, V; Böni, J; Yerly, S; Klimkait, T; Bürgisser, P; Garzoni, C; Hirschel, B; Cavassini, M; Battegay, M; Vernazza, P L; Bernasconi, E; Ledergerber, B; Günthard, H F (2011). Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitors. JAIDS Journal of Acquired Immune Deficiency Syndromes, 57(1):24-31.

Metzner, K J; Rauch, P; von Wyl, V; Leemann, C; Grube, C; Kuster, H; Böni, J; Weber, R; Günthard, H F (2010). Efficient suppression of minority drug-resistant HIV type 1 (HIV-1) variants present at primary HIV-1 infection by ritonavir-boosted protease inhibitor-containing antiretroviral therapy. Journal of Infectious Diseases, 201(7):1063-1071.

von Wyl, V; Ehteshami, M; Symons, J; Bürgisser, P; Nijhuis, M; Demeter, L M; Yerly, S; Böni, J; Klimkait, T; Schuurman, R; Ledergerber, B; Götte, M; Günthard, H F (2010). Epidemiological and biological evidence for a compensatory effect of connection domain mutation N348I on M184V in HIV-1 reverse transcriptase. Journal of Infectious Diseases, 201(7):1054-1062.

von Wyl, V; Ehteshami, M; Demeter, L M; Bürgisser, P; Nijhuis, M; Symons, J; Yerly, S; Böni, J; Klimkait, T; Schuurman, R; Ledergerber, B; Götte, M; Günthard, H F (2010). HIV-1 reverse transcriptase connection domain mutations: dynamics of emergence and implications for success of combination antiretroviral therapy. Clinical Infectious Diseases, 51(5):620-628.

Rieder, P; Joos, B; von Wyl, V; Kuster, H; Grube, C; Leemann, C; Böni, J; Yerly, S; Klimkait, T; Bürgisser, P; Weber, R; Fischer, M; Günthard, H F (2010). HIV-1 transmission after cessation of early antiretroviral therapy among men having sex with men. AIDS, 24(8):1177-1183.

Kouyos, R D; von Wyl, V; Yerly, S; Böni, J; Taffé, P; Shah, C; Bürgisser, P; Klimkait, T; Weber, R; Hirschel, B; Cavassini, M; Furrer, H; Battegay, M; Vernazza, P L; Bernasconi, E; Rickenbach, M; Ledergerber, B; Bonhoeffer, S; Günthard, H F (2010). Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland. Journal of Infectious Diseases, 201(10):1488-1497.

Alizon, S; von Wyl, V; Stadler, T; Kouyos, R D; Yerly, S; Hirschel, B; Böni, J; Shah, C; Klimkait, T; Furrer, H; Rauch, A; Vernazza, P L; Bernasconi, E; Battegay, M; Bürgisser, P; Telenti, A; Günthard, H F; Bonhoeffer, S; Swiss HIV Cohort Study (2010). Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load. PLoS Pathogens, 6(9):e1001123.

Clerc, O; Cavassini, M; Böni, J; Schüpbach, J; Bürgisser, P (2009). Prolonged seroconversion in an elite controller of HIV-1 infection. Journal of Clinical Virology, 46(4):371-373.

Müller, V; von Wyl, V; Yerly, S; Böni, J; Klimkait, T; Bürgisser, P; Ledergerber, B; Günthard, H F; Bonhoeffer, S (2009). African descent is associated with slower CD4 cell count decline in treatment-naive patients of the Swiss HIV Cohort Study. AIDS, 23(10):1269-1276.

Günthard, H F; Huber, M; Kuster, H; Shah, C; Schüpbach, J; Trkola, A; Böni, J (2009). HIV-1 superinfection in an HIV-2-infected woman with subsequent control of HIV-1 plasma viremia. Clinical Infectious Diseases, 48(11):e117-e120.

von Wyl, V; Yerli, S; Böni, J; Bürgisser, P; Klimkait, T; Battegay, M; Bernasconi, E; Cavassini, M; Furrer, H; Hirschel, B; Vernazza, P; Francioli, P; Bonhoeffer, S; Ledergerber, B; Günthard, H (2009). Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in Switzerland. Clinical Infectious Diseases, 48(7):979-987.

Isler, M; Huber, M; Günthard, H F; Böni, J (2009). Negativer HIV-Combitest trotz hoher HIV-1 Virämie bei einem Patienten mit akuter HIV-Infektion. Swiss Medical Forum, 9:87-88.

Scherrer, A U; Hasse, B; von Wyl, V; Yerly, S; Böni, J; Bürgisser, P; Klimkait, T; Bucher, H C; Ledergerber, B; Günthard, H F (2009). Prevalence of etravirine mutations and impact on response to treatment in routine clinical care: the Swiss HIV Cohort Study (SHCS). HIV Medicine, 10(10):647-656.

Damond, F; Benard, A; Ruelle, J; Alabi, A; Kupfer, B; Gomes, P; Rodes, B; Albert, J; Böni, J; Garson, J; Ferns, B; Matheron, S; Chene, G; Brun-Vezinet, F (2008). Quality control assessment of human immunodeficiency virus type 2 (HIV-2) viral load quantification assays: results from an international collaboration on HIV-2 infection in 2006. Journal of Clinical Microbiology, 46(6):2088-2091.

HIV Cohort Study, Switzerland; von Wyl, V; Yerly, S; Klimkait, T; Böni, J; Bürgisser, P; Battegay, M; Bernasconi, E; Cavassini, M; Furrer, H; Hirschel, B; Vernazza, P L; Rickenbach, M; Ledergerber, B; Guenthard, H F (2008). Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovir. Clinical Infectious Diseases, 46:1299-1309.

Joos, B; Fischer, M; Kuster, H; Pillai, S K; Wong, J K; Böni, J; Hirschel, B; Weber, R; Trkola, A; Günthard, H F (2008). HIV rebounds from latently infected cells, rather than from continuing low-level replication. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 105(43):16725-16730.

Yerly, S; von Wyl, V; Ledergerber, B; Böni, J; Schüpbach, J; Bürgisser, P; Klimkait, T; Rickenbach, M; Kaiser, L; Günthard, H F; Perrin, L (2007). Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey. AIDS, 21(16):2223-2229.

von Wyl, V; Yerly, S; Böni, J; Bürgisser, P; Klimkait, T; Battegay, M; Furrer, H; Telenti, A; Hirschel, B; Vernazza, P L; Bernasconi, E; Rickenbach, M; Perrin, L; Ledergerber, B; Günthard, H F; Swiss HIV Cohort Study (2007). Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types. Archives of Internal Medicine, 167(16):1782-1790.

Joos, B; Fischer, M; Schweizer, A; Kuster, H; Böni, J; Wong, J K; Weber, R; Trkola, A; Gunthard, H F (2007). Positive in vivo selection of the HIV-1 envelope protein gp120 occurs at surface-exposed regions. Journal of Infectious Diseases, 196(2):313-320.

Knuchel, M C; Jullu, B; Shah, C; Tomasik, Z; Stoeckle, M P; Speck, R F; Nadal, D; Mshinda, H; Böni, J; Tanner, M; Schüpbach, J (2007). Adaptation of the Ultrasensitive HIV-1 p24 Antigen Assay to Dried Blood Spot Testing. Journal of Acquired Immune Deficiency Syndromes, 44(3):247-253.

Bisset, L R; Böni, J; Lutz, H; Schüpbach, J (2007). Lack of evidence for PERV expression after apoptosis-mediated horizontal gene transfer between porcine and human cells. Xenotransplantation, 14(1):13-24.

Lötscher, M; Recher, M; Lang, K S; Navarini, A; Hunziker, L; Santimaria, R; Glatzel, M; Schwarz, P; Böni, J; Zinkernagel, R M (2007). Induced prion protein controls immune-activated retroviruses in the mouse spleen. PLoS ONE, 2(11):e1158.

Tehe, A; Maurice, C; Hanson, D L; Borget, M Y; Abiola, N; Maran, M; Yavo, D; Tomasik, Z; Böni, J; Schüpbach, J; Nkengasong, J N (2006). Quantification of HIV-1 p24 by a highly improved ELISA: An alternative to HIV-1 RNA based treatment monitoring in patients from Abidjan, Côte d'Ivoire. Journal of Clinical Virology, 37(3):199-205.

Schüpbach, J; Tomasik, Z; Knuchel, M C; Opravil, M; Günthard, H F; Nadal, D; Böni, J (2006). Optimized virus disruption improves detection of HIV-1 p24 in particles and uncovers a p24 reactivity in patients with undetectable HIV-1 RNA under long-term HAART. Journal of Medical Virology, 78(8):1003-1010.

Böni, J; Schüpbach, J; Rickenbach, M (2006). Rabbit retrotransposon sequences undetectable in blood donors and lymphoma patients of the Swiss HIV Cohort Study. AIDS Research and Human Retroviruses, 22(6):499-500.

Seemayer, C A; Böni, J; Steiger, J; Schüpbach, J; Mihatsch, M J (2006). No indication for activation of exogenous retroviruses in patients with renal allograft rejection. Clinical Nephrology, 65(5):324-327.

Brinkhof, M W G; Böni, J; Steiner, F; Tomasik, Z; Nadal, D; Schüpbach, J (2006). Evaluation of p24-based antiretroviral treatment monitoring in pediatric HIV-1 infection: prediction of the CD4+ T-cell changes between consecutive visits. JAIDS Journal of Acquired Immune Deficiency Syndromes, 41(5):557-562.

Schüpbach, J; Günthard, H F; Joos, B; Fischer, M B; Böni, J; Tomasik, Z; Yerly, S; Perrin, L; Battegay, M; Furrer, H; Vernazza, P; Bernasconi, E; Hirschel, B (2005). HIV-1 p24 may persist during long-term highly active antiretroviral therapy, increases little during short treatment breaks, and its rebound after treatment stop correlates with CD4(+) T cell loss. JAIDS Journal of Acquired Immune Deficiency Syndromes, 40(3):250-256.

Aceto, L; Karrer, U; Grube, Ch; Oberholzer, R; Hasse, B; Presterl, E; Böni, J; Kuster, H; Trkola, A; Weber, R; Günthard, H F (2005). Die akute HIV-1-Infektion in Zürich: 2002–2004. Praxis, 94(32):1199-1205.

Joos, B; Trkola, A; Fischer, M; Kuster, H; Rusert, P; Leemann, C; Böni, J; Oxenius, A; Price, D A; Phillips, R E; Wong, J K; Hirschel, B; Weber, R; Günthard, H F (2005). Low human immunodeficiency virus envelope diversity correlates with low in vitro replication capacity and predicts spontaneous control of plasma viremia after treatment interruptions. Journal of Virology, 79(14):9026-9037.

Deichmann, M; Huder, J B; Kleist, C; Näher, H; Schüpbach, J; Böni, J (2005). Detection of reverse transcriptase activity in human melanoma cell lines and identification of a murine leukemia virus contaminant. Archives of Dermatological Research, 296(8):345-352.

Shah, C A; Huder, J B; Böni, J; Schönmann, M; Mühlherr, J; Lutz, H; Schüpbach, J (2004). Direct evidence for natural transmission of small-ruminant lentiviruses of subtype A4 from goats to sheep and vice versa. Journal of Virology, 78(14):7518-7522.

Oxenius, A; Price, D A; Hersberger, M; Schlaepfer, E; Weber, R; Weber, M; Kundig, T M; Böni, J; Joller, H; Phillips, R E; Flepp, M; Opravil, M; Speck, R F (2004). HIV-specific cellular immune response is inversely correlated with disease progression as defined by decline of CD4+ T cells in relation to HIV RNA load. Journal of Infectious Diseases, 189(7):1199-1208.

Shah, C A; Böni, J; Huder, J B; Vogt, H R; Mühlherr, J; Zanoni, R; Miserez, R; Lutz, H; Schüpbach, J (2004). Phylogenetic analysis and reclassification of caprine and ovine lentiviruses based on 104 new isolates: evidence for regular sheep-to-goat transmission and worldwide propagation through livestock trade. Virology, 319(1):12-26.

Böni, J; Bisset, L R; Burckhardt, J J; Joller-Jemelka, H I; Bürgisser, P; Perrin, L; Gorgievski, M; Erb, P; Fierz, W; Piffaretti, J C; Schüpbach, J (2004). Prevalence of human T-cell leukemia virus types I and II in Switzerland. Journal of Medical Virology, 72(2):328-337.

Böni, J; Shah, C A; Flepp, M; Lüthy, R; Schüpbach, J (2004). Detection of low copy numbers of HIV-1 proviral DNA in patient PBMCs by a high-input, sequence-capture PCR (Mega-PCR). Journal of Medical Virology, 72(1):1-9.

Haupts, S; Ledergerber, B; Böni, J; Schüpbach, J; Kronenberg, A; Opravil, M; Flepp, M; Speck, R F; Grube, C; Rentsch, K; Weber, R; Günthard, H F (2003). Impact of genotypic resistance testing on selection of salvage regimen in clinical practice. Antiviral Therapy, 8(5):443-454.

Schüpbach, J; Böni, J; Bisset, L R; Tomasik, Z; Fischer, M; Günthard, H F; Ledergerber, B; Opravil, M (2003). HIV-1 p24 antigen is a significant inverse correlate of CD4 T-cell change in patients with suppressed viremia under long-term antiretroviral therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes, 33(3):292-299.

Shah, C A; Böni, J; Bisset, L R; Seebach, J D; Schüpbach, J (2003). Ultra-sensitive and specific detection of porcine endogenous retrovirus (PERV) using a sequence-capture real-time PCR approach. Journal of Virological Methods, 109(2):209-216.

Hasse, B; Hummel, Y; Böni, J; Schüpbach, J; Flepp, M; Günthard, H F (2003). 25-jähriger therapienaiver Patient mit einem dreiklassenresistenten HI-Virus. Praxis, 92(13):601-605.

Seemayer, C A; Kolb, S A; Neidhart, M; Ohshima, S; Gay, R E; Michel, B A; Gay, S; Böni, J; Schüpbach, J (2002). Absence of inducible retroviruses from synovial fibroblasts and synovial fluid cells of patients with rheumatoid arthritis. Arthritis and Rheumatism, 46(16):2811-2813.

Huder, J B; Böni, J; Hatt, Jean-Michel; Soldati, G; Lutz, Hans; Schüpbach, Jörg (2002). Identification and characterization of two closely related unclassifiable endogenous retroviruses in pythons (Python molurus and Python curtus). Journal of Virology, 76(15):7607-7615.

Minder, D; Böni, J; Schüpbach, J; Gehring, H (2002). Immunophilins and HIV-1 infection. Archives of Virology, 147(8):1531-1542.

Braun, U; Camenzind, D; Meli, M; Böni, J; Ossent, P (2001). Klinische Befunde und diagnostisches Vorgehen bei einem Milchschaf mit Visna. Schweizer Archiv für Tierheilkunde, 143(11):550-553.

Schüpbach, J; Böni, J; Flepp, M; Tomasik, Z; Joller, H; Opravil, M (2001). Antiretroviral treatment monitoring with an improved HIV-1 p24 antigen test: an inexpensive alternative to tests for viral RNA. Journal of Medical Virology, 65(2):225-232.

Bisset, L R; Bosbach, S; Tomasik, Z; Lutz, H; Schüpbach, J; Böni, J (2001). Quantification of in vitro retroviral replication using a one-tube real-time RT-PCR system incorporating direct RNA preparation. Journal of Virological Methods, 91(2):149-155.

Schüpbach, J; Tomasik, Z; Nadal, D; Ledergerber, B; Flepp, M; Opravil, M; Böni, J (2000). Use of HIV-1 p24 as a sensitive, precise and inexpensive marker for infection, disease progression and treatment failure. International Journal of Antimicrobial Agents, 16(4):441-445.

Fischer, M; Günthard, H F; Opravil, M; Joos, B; Huber, W; Bisset, L R; Ott, P; Böni, J; Weber, R; Cone, R W (2000). Residual HIV-RNA levels persist for up to 2.5 years in peripheral blood mononuclear cells of patients on potent antiretroviral therapy. AIDS Research and Human Retroviruses, 16(12):1135-1140.

Ledergerber, B; Flepp, M; Böni, J; Tomasik, Z; Cone, R W; Lüthy, R; Schüpbach, J (2000). Human immunodeficiency virus type 1 p24 concentration measured by boosted ELISA of heat-denatured plasma correlates with decline in CD4 cells, progression to AIDS, and survival: comparison with viral RNA measurement. Journal of Infectious Diseases, 181(4):1280-1288.

Bürgisser, P; Vernazza, P; Flepp, M; Böni, J; Tomasik, Z; Hummel, U; Pantaleo, G; Schüpbach, J (2000). Performance of five different assays for the quantification of viral load in persons infected with various subtypes of HIV-1. Swiss HIV Cohort Study. JAIDS Journal of Acquired Immune Deficiency Syndromes, 23(2):138-144.

Böni, J; Pyra, H; Gebhardt, M; Perrin, L; Bürgisser, P; Matter, L; Fierz, W; Erb, P; Piffaretti, J C; Minder, E; Grob, P; Burckhardt, J J; Zwahlen, M; Schüpbach, J (1999). High frequency of non-B subtypes in newly diagnosed HIV-1 infections in Switzerland. JAIDS Journal of Acquired Immune Deficiency Syndromes, 22(2):174-179.

Nadal, D; Böni, J; Kind, C; Varnier, O E; Steiner, F; Tomasik, Z; Schüpbach, J (1999). Prospective evaluation of amplification-boosted ELISA for heat-denatured p24 antigen for diagnosis and monitoring of pediatric human immunodeficiency virus type 1 infection. Journal of Infectious Diseases, 180(4):1089-1095.

Leutenegger, Christian M; Klein, D; Hofmann-Lehmann, Regina; Mislin, Caroline N; Hummel, U; Böni, J; Boretti, Felicitas S; Guenzburg, W H; Lutz, Hans (1999). Rapid feline immunodeficiency virus provirus quantitation by polymerase chain reaction using the TaqMan fluorogenic real-time detection system. Journal of Virological Methods, 78(40575):105-116.

Schüpbach, J; Böni, J (1998). Sensitivity of heat-denatured p24 antigen in the diagnosis of pediatric HIV infection. Journal of Acquired Immune Deficiency Syndromes, 18(4):399-400.

Conrad, B; Weissmahr, R N; Böni, J; Arcari, R; Schüpbach, J; Mach, B (1997). A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes. Cell, 90(2):303-313.

Böni, J; Opravil, M; Tomasik, Z; Rothen, M; Bisset, L; Grob, P J; Lüthy, R; Schüpbach, J (1997). Simple monitoring of antiretroviral therapy with a signal-amplification-boosted HIV-1 p24 antigen assay with heat-denatured plasma. AIDS, 11(6):F47-F52.

Weissmahr, R N; Schüpbach, J; Böni, J (1997). Reverse transcriptase activity in chicken embryo fibroblast culture supernatants is associated with particles containing endogenous avian retrovirus EAV-0 RNA. Journal of Virology, 71(4):3005-3012.

Schüpbach, J; Flepp, M; Pontelli, D; Tomasik, Z; Lüthy, R; Böni, J (1996). Heat-mediated immune complex dissociation and enzyme-linked immunosorbent assay signal amplification render p24 antigen detection in plasma as sensitive as HIV-1 RNA detection by polymerase chain reaction. AIDS, 10(10):1085-1090.

Jendis, J; Strack, B; Volkmann, S; Böni, J; Mölling, K (1996). Inhibition of replication of fresh HIV type 1 patient isolates by a polypurine tract-specific self-complementary oligodeoxynucleotide. AIDS Research and Human Retroviruses, 12(12):1161-1168.

Schüpbach, J; Pyra, H; Jendis, J; Tomasik, Z; Böni, J (1996). Isolation of an in vitro transmissible agent with reverse transcriptase activity from a blood donor with a borderline-positive HIV-1 serology for more than five years. Clinical and Diagnostic Virology, 5(2-3):197-203.

Böni, J; Pyra, H; Schüpbach, J (1996). Sensitive detection and quantification of particle-associated reverse transcriptase in plasma of HIV-1-infected individuals by the product-enhanced reverse transcriptase (PERT) assay. Journal of Medical Virology, 49(1):23-28.

Böni, J; Stalder, J; Reigel, F; Schüpbach, J (1996). Detection of reverse transcriptase activity in live attenuated virus vaccines. Clinical and Diagnostic Virology, 5(1):43-53.

Pyra, H; Böni, J; Schüpbach, J (1994). Ultrasensitive retrovirus detection by a reverse transcriptase assay based on product enhancement. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 91(4):1544-1548.

Böni, J; Schüpbach, J (1993). Sensitive and quantitative detection of PCR-amplified HIV-1 DNA products by an enzyme linked immunoassay following solution hybridization with two differently labelled oligonucleotide probes. Molecular and Cellular Probes, 7(5):361-371.

Böni, J; Emmerich, B S; Leib, S L; Wiestler, O D; Schüpbach, J; Kleihues, P (1993). PCR identification of HIV-1 DNA sequences in brain tissue of patients with AIDS encephalopathy. Neurology, 43(9):1813-1817.

Schüpbach, J; Böni, J (1993). Quantitative and sensitive detection of immune-complexed and free HIV antigen after boiling of serum. Journal of Virological Methods, 43(2):247-256.

This list was generated on Tue Oct 24 12:48:09 2017 CEST.